Evidence-Based Teen Pregnancy Prevention Programs Receive HHS Awards
The U.S. Department of Health and Human Services (HHS) announced approximately $23 million in funding to foster innovation, provide new research and expand the evidence to support and advance equity in the Teen Pregnancy Prevention program.
First Drugs Selected for Medicare Drug Price Negotiation
The U.S. Department of Health and Human Services announced the first 10 drugs covered under Medicare Part D selected for negotiation as part of the Inflation Reduction Act.
OCR Issues Resources to Educate Patients about Telehealth and the Privacy and Security of Protected Health Information
The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services has issued two resource documents to help explain to patients the privacy and security risks to their protected health information when using telehealth services and ways to reduce these risks.
Protein Identified That Can Cause Cancer Cells to Die
Scientists at the University of California, Davis have identified a protein on the CD95 receptor that can “program” cancer cells to die.
First Treatment Approved for Genetic Clotting Disorder
The U.S. Food and Drug Administration has approved a recombinant ADAMTS13 protein product (Adzynma) as a prophylactic or on-demand enzyme replacement therapy for patients with congenital thrombotic thrombocytopenic purpura.
First Vaccine for Mosquito-Born Viral Disease Is Approved by FDA
The U.S. Food and Drug Administration has approved IXCHIQ, Valneva’s single-dose, live-attenuated vaccine indicated for the prevention of disease caused by chikungunya virus in individuals 18 years of age and older who are at increased risk of exposure to CHIKV.
FDA Approves Zepbound as a New Weight-Loss Drug
The U.S. Food and Drug Administration has approved Eli Lilly’s tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well.
Efgartigimod Efficacious in Treating Chronic Immune Thombocytopenia
A new study shows efgartigimod significantly increased sustained platelet count responses compared with placebo in patients with chronic immune thrombocytopenia, including those who had received multiple previous immune thrombocytopenia therapies.
New mRNA-Based Therapy Effective in Treating Melanoma in Mouse Models
Investigators at the Icahn School of Medicine at Mount Sinai have designed an RNA-based strategy to activate dendritic cells, which play a key role in immune response, that eradicated tumors and prevented their recurrence in mouse models of melanoma.
Combination of IVIG and Corticosteroids Superior to Respective Monotherapies for Treatment of Relapsed ITP in Adults
The combination of intravenous immune globulin (IVIG) and corticosteroids is a more efficient and rapid treatment for relapsed immune thrombocytopenic purpura (ITP) in adults compared with the use of either therapy alone.
